Rutgers Cancer Institute of New Jersey Secures Grants & Pursues T-Cell Acute Lymphoblastic Leukemia

Rutgers Cancer Institute of New Jersey Secures Grants & Pursues T-Cell Acute Lymphoblastic Leukemia

Rutgers Cancer Institute of New Jersey received over $2 million in grants recently to study potential treatment targets for a rare and aggressive blood cancer called T-cell acute lymphoblastic leukemia (T-ALL). The recent grant awards were reported by Rutgers Cancer...

Pin It on Pinterest